Ukrainian Pharmaceutical Forum

7-8 November 2018

Speaker confirmations in 2018

Oleg Petrenko, the Head of National Health Service of Ukraine, was born on 4 October 1974 in Nizhyn, Chernihiv region. He graduated Vinnytsya National Pirogov Memorial Medical University in 1998, School of Public Health of Kyiv-Mohyla Academy and Maastricht University with master degree in management of health institutions and School of Political Studies of the Council of Europe in 2006. 

He started his professional career in leading Ukrainian pharmaceutical companies where he took various positions starting from medical representative until business unit head. From 2005 until 2007, he worked as Executive Director in the School of public health of Kyiv-Mohyla Academy. Starting from 2007, he has been working in Kyiv private hospitals. From 2007 until 2015, he was Director on strategic development and First Deputy of General Director in the Oberih hospital. From 2015 until February 2018, he worked as Deputy General Director on strategic development in Isida hospital.  

From 2005 until 2007, he took the position of External Adviser and Member of working groups of the Ministry of health, Ministry of social policy and Presidential administration on developing draft laws in medical sphere. From 2005 until 2008, he was Member of Civic Council of the Ministry of health. From 2014 until 2015, he was Member of Strategic Advisory Group on elaborating national strategy for development of Ukrainian health system for 2015-2020. 

On 27 February 2018, Oleg Petrenko won the competition to fill the position of the Head of newly established National Health Service of Ukraine. During six months of his job, half of the Ukrainian primary health care institutions signed the contract with the National Health Service and implemented new financing system. More than 12 million of Ukrainians chose his own doctor in these institutions. The National Health Service should provide financing of all medical institutions and reimbursement of medicines up to the year 2020. 

 

 

 

Inna Shatova has been working in the Ministry of economic development and trade of Ukraine on the position of Deputy Director of industrial property department, the Head of industrial property law unit.
Inna Shatova, the highly qualified professional in intellectual property, has more than 20 years of working experience in this sphere. Before the abolition of the State service of intellectual property, she occupied the position of Deputy Director of the industrial property department, the Head of industrial property unit of the Service.
Inna graduated Kyiv polytechnic institute with bachelor degree in chemical engineering and Interregional academy of personnel management with master degree in juridical sciences as well as she obtained special education in intellectual property.
Inna Shatova is occupied in development of legislation in the sphere of industrial property, administrative protection of intellectual property rights, fulfilment of the Ukrainian obligations under international treaties etc.
Inna is also Member and Deputy Head of the Appeals Chamber under the Ministry of economic development and trade.

 

Ksenya Lyapina was born on 5 May 1964 in Kyiv. She graduated Kyiv Polytechnic Institute with bachelor degree in mathematics and master degree in legal regulation of the economy.

In 1987, she started her career in Kyiv plants “Generator” and “Octave”. In 1992-1997, she worked in computing systems laboratory of the scientific center of radiation medicine as engineer and junior researcher. In 1997-1999, she took the position of leading specialist in computer services in Kyiv city council of trade unions “Yednannya”. From February 1999, she led projects in the Association of private business assistance “Yednannya”. In 1999-2005, she was private entrepreneur and Advisor of Ukrainian Prime Minister on a voluntary basis. She led also Business Council under the Cabinet of Ministers.

Starting from 2005 until 2014, she was People’s Deputy of the Verkhovna Rada of Ukraine, Deputy Chairman of Committee on industrial policy and entrepreneurship (2005-2006), Chairman of Subcommittee on regulatory policy and entrepreneurship (2006-2007), Deputy Chairman of Committee on industrial and regulatory policy and entrepreneurship (2007-2012), Deputy Chairman of Committee on economic policy (2012-2014).

She is author of more than 50 scientific and teaching methodological works. She was awarded the Order of Merit. She is married; she has a son, daughter and grandchildren.

On 9 January 2015, she was appointed Head of State Regulatory Service of Ukraine by the order of the Cabinet of Ministers.

Volodymyr Kostiuk was appointed the Acting Executive Director in March 2018. Before that, he had held the position of the Operations Director of the company since June 2015. Before that, he was the chief of the liquid and semisolid medicinal products manufacturing shop. He has worked in the Company since 2008.

Volodymyr Kostiuk worked on establishing contacts with foreign partners and development of pharmaceutical enterprise’s international cooperation. He participated in clinical trials of preparations manufactured by Farmak in Europe, Canada and the US. Volodymyr Kostiuk headed the team in charge of the operation of SAP ERP, a business automation system, and was responsible for internal audits in the company.

Volodymyr Kostiuk is responsible for development and implementation of the company strategy in manufacturing operations, introduction of efficient business processes into production, management of production activities of the enterprise and processes of development and expansion of production.

In 2009, he graduated from Taras Shevchenko National University of Kyiv with a degree in Economic Cybernetics. He studied at Donau Universitat Krems (Austria) under the MBA program.

Now he is studying at National University of Pharmacy, Kharkiv to obtain a degree in Pharmaceutical Engineering.

null

Since March 2016, Guilhem Granier serves as Country Chair and General Manager for Sanofi Ukraine, providing his responsible leadership to ensure uninterrupted access to Sanofi’s innovative medicines for Ukrainian patients.

Guilhem has about 18 years of marketing and operational experience in pharma business. He started his professional career as a Sales Representative in Rhone-Poulenc-Theraplix in 1999 in France, rising shortly to the position of Group Product Manager in Sub-Saharan Africa, being in charge of cardiovascular products. From 2002 to 2007, Guilhem held several positions within the French Headquarter of Aventis pharmaceutical company, serving the French affiliate as Product Manager for Lantus and then global markets as Established Products Portfolio Manager. In 2007, Guilhem Granier joined Sanofi Tunisia as Business Unit Head for CHC & Generics. In 2009, he was appointed as General Manager for Tunisia & Libya. In 2012, Guilhem took the role of Business Excellence Director for a region covering Africa, Middle East, Eurasia and South Asia.

Guilhem holds a Doctor of Pharmacy degree from the University of Montpellier and a Master’s degree in Marketing and Management from the ESSEC School of Management. Guilhem is married and has 3 children. In his spare time, Guilhem is an enthusiastic traveler, has a passion for history and enjoys reading books.

Elena graduated from Belarus State Medical University in 1996. She worked as an obstetrician-gynecologist in the Hospital of the Presidential Administration, Minsk.

Elena started her career in pharmaceutical business in KRKA in 2003. She joined GSK in 2005 and worked for more than 10 years in different commercial roles in GSK Belarus passing the way from a medical representative to the Country Manager of GSK Pharma in Belarus. In 2016 Elena Likhovets was appointed to a position of the General Manager of GSK Pharma Ukraine.

 

Somer holds a Bachelor of Science in Pharmacy from Istanbul University, Turkey and an MBA from Kent Business School, UK. He joined GSK Turkey as a product manager in 2009 and held different commercial positions such as Project Manager (Emerging Markets), Regional Vaccines Commercial Head (MENA/CIS), Vaccines Business Unit Head (Near East) and General Manager (Caucasus). In his current role, Somer is responsible for GSK Pharma operations in CIS Export Markets.

Dejan Nesic is General Manager of Roche Ukraine (medical doctor by education) where he leads  50 employees affiliate and have responsibility for overall Roche business in Ukraine including marketing, medical, commercial and access teams.

Before starting to work in Ukraine Dejan grew the business in several countries including Serbia, Montenegro and has waste experience in pharma marketing and people management.

Dejan enjoys books of Aldous Huxley and tennis.

 

Roger Elia is the General Manager of Merck Biopharma in CIS

Born in 1976 in Lebanon. Roger holds MBA in Finance & Marketing. Roger lived and worked in Lebanon, Russia, CIS and South Korea. Since 2018 he has been living and working in Russia.

 Professional background

2018 – now
General Manager of Merck Biopharma in CIS
2015– 2018
Business Unit Head at Merck Ltd Korea
2014 – 2015
Strategic Alliance Leader at Merck LLC Russia
2011 – 2014
Marketing Manager at Merck LLC Russia
2009– 2011
Market Access and Pricing Head at Novartis Oncology Russia
2003– 2009
Various management positions at Pharmonyx Ltd in Russia and CIS
1994 – 2003
Medical Academy, Moscow

Dmytro Spitsyn joined Teva Ukraine as General Manager in July 2014. Under his leadership the company has successfully completed integration with Actavis and became one of three largest pharmaceutical companies in Ukraine. 

Dmytro has more than 20 years of experience in pharmaceutical industry. Prior to joining Teva, he held leadership positions in ViiV Healthcare Russia/CIS and ViiV Healthcare International, GSK and Pharmastart LLC.

Dmytro graduated from the Bohomolets National Medical University with MD degree. He holds MBA degree from Management Institute MIM-Kiev (2002). 

He has two daughters, he and his family live in Kyiv.

 

Alexandra Sologub, MD, MBA, is Director of “Likravy” Ukraine, belonging to the nature network® - the group of companies, managed as a family company in its third generation and operated internationally in more than 60 countries. The nature network® offers a broad spectrum of products and services: from botanicals and their refinement into premium-quality base materials, to laboratory, consultancy and distribution services.
Alexandra has an experience of approximately 20 years in Pharma industry; she has worked in different organizations like GSK, Teva, Darnitsa.

Dr Oleksandr Gorbenko is an expert in public health, patient advocacy and engagement with overall 18 years experience in pharma. He graduated as a medical doctor (general practice) in O.Bogomolets National Medical University and Shupyk National Medical Academy of Postgraduate Education and later worked on his PhD dissertation in the Ukrainian Institute of Public Health MOH. His experience across pharma includes several medical and commercial roles in representative offices of big biopharma companies (Nycomed/Takeda, Richter Gedeon, GSK) as well as senior global medical roles at GSK and ViiV Healthcare headquarters in the UK. He has an additional experience with UN/UNFPA on women empowerment and combating gender-based violence.  Over the last 5 years Dr Gorbenko has been developing necessary capacities/capabilities within corporate patient affairs focusing on getting insights, advice and information from patients throughout the Medicine Development Continuum and disease continuum/individual experience, collaboration with patient organisations, substantiation and inclusion of the specific PRO/PCO measurements, KPIs and standards of patient centricity for big pharma and other programmes. ViiV Healthcare has been broadly recognised as a truly patient-centric company (Number 1 amongst 47 biopharma companies over the last 5 years by PatientView Corporate Reputation Ranking) and reliable partner of HIV community.

 

Rajeev Gupta was born in India on 18.04.1970.

 In 1988, he came to Ukraine to study engineering. In 1994, he graduated from the Kyiv Polytechnic Institute.

 In 1995, he began working in the pharmaceutical industry, having established a distribution company specializing in the supply of Indian pharmaceutical products to Ukraine.

 In 2001, the company “Gladpharm LTD”, headed by Rajeev Gupta, was among ten largest pharmaceutical distributors in Ukraine.

 Since 2002, Rajeev Gupta began to market the medicinal products under his own brands. The medicinal products were manufactured on a contractual basis in India. After successful launching of more than a dozen drugs on the market Rajeev Gupta decided to create his own drug manufacturing.

 In 2005, the construction of Kusum Healthcare Pvt Ltd pharmaceutical plant began in India, and since 2007, most of the company’s medicinal products are manufactured at its own plant. Given the importance of the Ukrainian market for the company, in 2005 a decision was made to build a pharmaceutical plant in Ukraine.

 In August 2009, “Kusum Pharm” plant was put into operation in Sumy. Both plants of the company are constructed in accordance with GMP standards.

 The products manufactured by Kusum group of companies are sold in Ukraine, India, Kazakhstan, Uzbekistan, Moldova, Philippines, and Myanmar.

 Kusum group of companies is included in the TOP 11 pharmaceutical companies of Ukraine, and is recognized to be one of the most rapidly growing companies in the pharmaceutical industry.

Pechaeva Tatiana Valerievna, a General Director of 'Lekhim' group, was born on 25th April, in 1914 in Odessa. In 1996 she graduated from Ukrainian State University of Food technologies with a Biotechnology specialisation. Tatiana has been working for Lekhim since 1996. She has made her way from a junior specialist to General Director and Deputy Head  of Board of Directors.

Tatiana's hobbies are travelling, theatre, preference game. Tatiana is married and she has got a daughter and a son.

 

Vitaliy has been working as a Country Manager in AbbVie Biopharmaceuticals GmbH for 5 years. He also worked for such companies as  Abbott Ukraine Ltd., Janssen-Cilag, KRKA.

Vitaliy has a successful experience in managing sales and marketing teams in international pharmaceutical companies. He has a wide business connection in the field of pharmaceutical market (Ukraine and Moldova). Competent in marketing, sales, conducting negotiations and managing different organizations, teams and projects.

Vitaliy is a member of the following organisations:

APRaD (Association of Pharmaceutical Research and development): BoD
Chairman of the Board

ACC (American Chamber of Commerce) Co-chair of HC committee since 2013
USUBC (US-Ukraine business council) BoD member since 2008

 

Deepak Sharma is Director of Glenmark Ukraine, belonging to Glenmark Pharmaceuticals Ltd., an International pharma company with presence over 80 countries. Glenmark Pharma Ranks among top 80 Pharma & Biotech companies globally. (SCRIP 100 Rankings 2017). Glenmark pharma has 17 manufacturing facilities across US, India, Czech Republic, Argentina and Switzerland.

In addition to Ukraine, Deepak is also looking after Moldova, Georgia and Azerbaijan. In this role, Deepak is responsible for overall operations of the organization.

Deepak has an experience of apprx 15 years in Pharma industry, he has worked in different organizations like Cipla, Pfizer, Ranbaxy & Macleods on different positions. He is based in Ukraine from last 7 years and travelled extensively inside the region including, Ukraine , Kazak, Uzbek, Georgia, Azerbaijan and Moldova. He possesses a good knowledge of the pharma industry in the region. He has a vision to develop the pharma marketing more interesting and innovative. He is instrumental in many of the ongoing CSR projects in the region.

Deepak holds a Management degree, in addition to the life-sciences degree. Deepak has spoken on various issues on various platform related to pharma Industry. He is often invited by management colleges for talk to inspire students. In the recent past , Deepak was interviewed by Pharmaboard room and Medicinman. His interview on his career was published in Medicinman last year.

Deepak lives in Kyiv with wife and 2 children.

Volodymyr Ignatov is the Head of IPSEN Pharma country office in Ukraine and Moldova.

Volodymyr Ignatov has more than 20 years of experience in Ukrainian pharmaceutical market as a Head of country office of the companies Rhone-Poulenc Rorer (1993-1999), Aventis (2000-2005), Astra Zeneca (2005-2009) and IPSEN.

In 2001-2009, he was actively engaged in work of the European Business Association (EBA) as Vice President (2004-2005), Head of European pharmaceutical manufacturers group by the EBA Health Care Committee.  

Since 2010, he has been working as Executive Director in AIPM Ukraine.

Education:

Bogomolets National Medical University in Kyiv, Candidate of medical sciences, MBA.

 

Irina Karakai has more than 20 years of business experience in pharmaceutical market in Ukraine, in general management, leading the organizations as Country/Region Head in several international companies: Novartis, Boehringer Ingelheim, Jadran Galenski Laboratorij.

Besides Ukraine, during last 15 years she is being involved in development of business in various other CIS countries

Irina Karakai holds a degree in Medicine from the University of Lugansk, PhD in Marketing from the University of Kiev and MBA degree from University of Pittsburgh’ Joseph M.Katz Graduate School of Business. 

Has broad experience in building and structuring the organizations, market access, sales & marketing, HR, development of personal, Supply Chain management, building the cross-functional cooperation, project management, etc.

 

 

Being a Candidate of Medical Science Julia started her career as practitioner pathologist and lecturer at Donetsk National Medical University.  A pharmaceutical business path was opened in 1994 from medical representative in Ipsen. Since then her career has been evolving together with the industry itself. At early stages, she took various positions as first-line sales manager, national sales manager and trainer-coach for medical representatives. During 2005 -2007 she got exposure to functions in marketing, portfolio management, Rx and OTC products development as a marketing manager in Nycomed. Next 5 years she was challenged by above-market decision-making as Business Unit Head in Novartis Oncology CIS Region. After obtaining this unique experience in different markets and different healthcare systems, she continued to work in hospital business for Astellas Pharma, building up new market access models and marketing strategies for innovative hospital brands. 

Twenty-five years of various roles have made her known as one of the experts of pharmaceutical business in Ukraine.  For the last 3 years, Julia has been a country manager in Alvogen Ukraine, bringing the startup to the double-digit growth numbers.

Alexander Tkachuk graudated from Canada New Brunswick University with international MBA. He also has a 'Marketing degree' from Economical University in Kiev and degrees from the Institute of Pharmacology at Academy of Medical Science, Kiev and National Medical University, Kiev.  

Before his role as a Country Manager in the Representative Office Sentiss Pharma, and current role in Zylotech Ukraine,  Alexander used to be  a Head of Business Support & Development department in the representative office of  Sanofi in Ukraine, General Manager at COMCON Pharma (Ukraine) and Deputy Country Manager at the  Representative office of Mega Products in Ukraine.

 

 

Juliette Passer is an accomplished senior executive steeped in International, and the ability to help companies accelerate their penetration and growth in the United States and abroad. She has performed successfully in that role for over twenty-five years, also serving as counsel to the legal implications and nuances of these expansions. Additionally, Juliette brings to the equation an extensive background in working with governments, and political organizations as well as multilateral institutions, to achieve these corporate goals for private companies. As such, she brings a unique business and legal understanding of international business transactions and business and political environments in architecting cross-border investments. She is particularly adept knowledgeable in markets including the former USSR, Eastern and Western Europe, China, Turkey, and Panama. Finally, Juliette has extensive experience on numerous private Boards, and is available for suitable Board engagements.
Following the completion of her legal studies, Juliette gained her early legal and international experience as corporate Associate with the New York offices of Debevoise & Plimpton, as well as Patterson, Belknap Webb & Tyler, LLP. She gained exposure to corporate finance, general corporate practice, and international development for clients. Her responsibilities included negotiating lending, stock purchase, licensing, distribution and joint venture agreements, in addition to opening a Moscow office. She trained Ukrainian and Russian attorneys under the auspices of the American Bar Association and Council for Trade and Economic Cooperation. Juliette is a Life Member of the Council on Foreign Relations and member of the National Association of Corporate Directors.
Today, Juliette is General Counsel of the International Project Development Group, a New York practice specializing in the broad range of domestic and international transactions, representing both US and foreign clients. Since 1996, they have been counsel in sectors ranging from aviation, to pharmaceuticals, telecomm, manufacturing, entertainment, and petrochemicals.
Additionally, Juliette has brought her expertise to thousands of individuals through her teaching engagements, seminars and courses. She has lectured US and international audiences on issues of law and commerce, with a particular expertise in emerging markets and the Internet.

Pavlo is a regional legal manager and a certified compliance officer with 10+ years of experience in cross-border multimillion business deals and litigation, as well as ethics, compliance and risk. He graduated from National Aviation University of Ukraine and continued his studies in Tilburg University, where he got his master’s degree in international business law. Almost 7 years of his professional experience in the legal field derives from supporting pharmaceutical businesses (GlaxoSmithKline and Dr. Reddy’s Laboratories). Currently Pavlo holds a position of regional head of legal and deals with vast variety of legal issues in Ukraine, Kazakhstan, Uzbekistan, Belarus, Romania (and Kosovo, Moldova, Albania). He deals with corporate & commercial, anti-corruption & competition, employment & labor, advertising & personal data protection, patents & criminal as well as other areas of law. Pavlo is an attorney at law admitted to the bar in Ukraine in 2013 with a record in domestic litigation. In 2016 Pavlo was awarded as a winner of International Bar Association (IBA) scholarship, which allowed to attend IBA conferences in Washington DC (2016) and Rome (2018).

For 5 years Pavlo led compliance function in CIS & Romania region. He is a certified compliance professional (CCEP-I) and a co-founder of Complianceperiscope Blog, which is devoted to corporate ethics and compliance in Ukraine and the world. Pavlo was recognized as the best compliance officer of Ukraine in 2017 according to Ukraine’s most reputable legal publisher Yuridychna Practica and in 2018 was elected as a co-chair of the American Chamber of Commerce Compliance Club.”

Volodymyr has a higher medical education and started his working career since 1988 at the Kyiv Research Institute of Pediatrics, Obstetrics and Gynecology as researcher at Laboratory of Pathology. From 1996 to 2013 he held senior positions in international pharmaceutical companies Leiras (Head of Representative Office - 1996), Schering AG (Business Unit Director and Marketing & Sales Director - 1997-2007) and Bayer (Head of Business Unit Women’s Healthcare - 2007-2010, Country Division Head Dermatology Ukraine&Belarus - 2010-2013). He holds a Ph.D. in Psychology, 2004. Volodymyr has been working since 2014 as Executive Director of Association of Pharmaceutical Research & Development (APRaD).

 

Vasyl started his professional career in 2000 with C&S Wholesale Grocers, Westfield, MA as Training Supervisor. Upon return in Ukraine in 2003 and until 2014 he worked as a consultant on a wide range of international technical assistance projects in health financing, patient access to treatment, etc, funded by the EU Commission, the World Bank and the UNDP.  In 2014 he joined Pfizer Ukraine as Public Affairs and Healthcare Policy Manager. Now he is PA and Market Access Lead for Ukraine, Belarus and Georgia, Armenia and Azerbaijan.

Vasyl holds Master of International and Intercultural Management degree from the World Learning’s School for International Training, Brattleboro, VT; Post-Graduate Diploma in World Politics Degree from the London School of Economics and Political Science and Specialist, MSc in Philology from ‘Bogdan Khmelnitsky’ Cherkassy State University with honors.

 

Leonid received his Master of Law degree at The Yaroslav Mudryi National Law University and reinforced his academic background by studying Economics, Finance and Credit at V.N. Karazin Kharkiv National University.

He joined Sanofi Ukraine in 2015, having brought the extensive experience he gained as an associate at Ukraine’s leading law firms.

As Head of Legal, Mr. Cherniavskyi is providing in-depth, legal, business-focused advice to the business, identifying and assessing the issues impacting legal risk while keeping a special focus on setting standards and reinforcing a culture of integrity, quality, ethical behavior and responsibility across the Sanofi business in Ukraine.

SUR Sergii (24.07.1961, Zaporozhie, Ukraine) — Candidate of Chemical Sciences (1988), Doctor of Pharmaceutical Sciences (2005), Director of "ARTERIUM LTD." (2018).

Education: Zaporozhie State Medical Institute, Pharmaceutical Faculty (1983), Postgraduate studentship of Institute of Colloid Chemistry and Chemistry of Water, Ukrainian Academy of Sciences, Kiev (1988)

Work Record:

·          Deputy Head of the Central District Pharmacy in Berezovka city, Odessa region (1983);

·          Post graduate student (1985), scientific associate (1989)  of Institute of Colloid Chemistry and Chemistry of Water, Ukrainian Academy of Sciences;

·          Scientific associate in Scientific Hygienic Center, Ukrainian Academy of Medical Sciences (1992);

·          Head of State Laboratory for Quality Control of Medicines, Institute of Pharmacology and Toxicology, Ukrainian Academy of Medical Sciences (1993),

·          Director of Central Laboratory for Quality Control of Medicines, MoH of Ukraine (1998),

·          Deputy Chief Inspector of Ukraine for Quality Control of Medicines, MoH of Ukraine (2000),

·          Director of Research and Development of "Arterium" Corporation (2005), Regulatory Affairs Director of "Arterium" Corporation (2013)

·               Director of "ARTERIUM LTD." (2018).

Role and Duties:

Developing and submission of functional strategy in R&D, RA

Development and implementation of R&D and RA business processes and structure

Research, development and marketing authorization of new products on all markets

Member of Company Directors Board

 

 

 

 

From September 2017, Alexey Sukhomlinov has been taking the position of Deputy Director on quality in State enterprise “Ukrainian pharmaceutical quality institute” (UPQI). Before then, Alexey worked in State enterprise “State training center on good manufacturing and distribution practices” (further restructured to “UPQI”) and was engaged in more than 100 GMP inspections.

Total length of work in the industry is more than 20 years: “Kyivmedpreparat”, “Pharma Start”, “Dr. Reddy”s Laboratories”. 

 

Alla has been woring as a Director of Medical and Regulatory Affairs department, PV, QA Ukraine and CIS in Acino Pharma AG, Pharma Start LLC Ukraine since 2015. From 2003 to 2015 she was a medical representaive to RA, Medical, PV, QA Director in group of countries at Nycomed (Switzerland), Takeda Pharmaceutical (Japan). Alla graduated as a MD from National Medical University (Ukraine, Kiev) in 2003. Alla has a PhD in Pediatrics.

Daria graduated from Kyiv National University of Trade and Economics, with MA degree in Finance and Credit as Financial analyst. She has a degree in Commercial Law from Kyiv National University of Trade and Economics, in Law from Vadym Getman Kyiv National Economic University.

Legal career of D. Bondarenko began in the Kyiv City Clinical Hospital No. 1 of the Main Health Department of the Kyiv City State Council (KCSC) as a lawyer of the special fund health insurance department.

At the same time, Daria Bondarenko was an assistant-consultant of the deputy head of Main Health Department of the KCSC  (now KCSC Health Department).

By the decision of AMOMD founders general meeting D. Bondarenko was elected at Nov. 7, 2012 to the position of Executive Director and combined this work in Nov. 2014 with a legal practice in leading law company “Legal Alliance”.

According to Association Article the Executive Director represents AMOMD in relations with central and local authorities, other state and non-governmental Ukrainian, foreign and international organizations, enterprises, individuals and acts on behalf of the Association.

Implemented projects with D. Bondarenko participation:

• Draft Law No. 3180 “On the amendments to the item 193.1 “в” of article 193 of the Tax Code of Ukraine” dated by Sep. 25, 2015;

• Cabinet of Ministers Resolution No. 181 “On the amendments of certain CMR decrees” dated by May 27, 2014;

• Cabinet of Ministers Resolution No. 215 “On the amendments of certain CMR decrees” dated by July 01, 2014;

• Cabinet of Ministers Resolution No. 216 “On approval of medical devices, which operations for delivery in the customs territory of Ukraine and importation into the customs territory of Ukraine are to be taxable for VAT at the rate of 7 percents” dated by July 01, 2014;

• Cabinet of Ministers Resolution No. 240  “On the amendments of certain CMR decrees” dated by March 23, 2016;

• Cabinet of Ministers Resolution No. 501   “On Amendments to the CMR reglament (in respect of changes to item 2 of paragraph 40 for Chapter 3)” dated by Aug. 08, 2016;

• Cabinet of Ministers Resolution No. 43 ‘On Amendments to the CMR order of Oct. 17, 2008, No. 955 and to the CMR order of Jul. 02, 2014, No. 240” dated by January 25, 2017 – regarding the cancellation of change declaring of the wholesale-sale price for medical devices;

• MHU order No. 660 “On the recognition of the MHU order of Dec. 29, 2011, No. 1000, as invalid one” dated by Oct. 09, 2015;

• MHU order No.361 “On amending the MHU order of July 16, 2012 No. 533” dated by April 13, 2016.

Practices

Pharmaceutic regulation, legal regulation of medical devices legalization, price control and VAT taxation of medical devices, technical regulation of medical devices, regulatory activity

Membership

• working group of Ministry of Economic Development and Trade of Ukraine on improving the assessment of compliance of legislatively regulated measuring instruments used to ensure the protection of citizens life and health;

• working group on the legislation improvement in the sphere of medicinal products circulation of the Ministry of Health of Ukraine;

• community council attached to AMCU;

• Ukrainian Bar Association (UBA)

 

SUR Sergii (24.07.1961, Zaporozhie, Ukraine) — Candidate of Chemical Sciences (1988), Doctor of Pharmaceutical Sciences (2005), Director of "ARTERIUM LTD." (2018).

Education: Zaporozhie State Medical Institute, Pharmaceutical Faculty (1983), Postgraduate studentship of Institute of Colloid Chemistry and Chemistry of Water, Ukrainian Academy of Sciences, Kiev (1988)

Work Record:

·          Deputy Head of the Central District Pharmacy in Berezovka city, Odessa region (1983);

·          Post graduate student (1985), scientific associate (1989)  of Institute of Colloid Chemistry and Chemistry of Water, Ukrainian Academy of Sciences;

·          Scientific associate in Scientific Hygienic Center, Ukrainian Academy of Medical Sciences (1992);

·          Head of State Laboratory for Quality Control of Medicines, Institute of Pharmacology and Toxicology, Ukrainian Academy of Medical Sciences (1993),

·          Director of Central Laboratory for Quality Control of Medicines, MoH of Ukraine (1998),

·          Deputy Chief Inspector of Ukraine for Quality Control of Medicines, MoH of Ukraine (2000),

·          Director of Research and Development of "Arterium" Corporation (2005), Regulatory Affairs Director of "Arterium" Corporation (2013)

·               Director of "ARTERIUM LTD." (2018).

Role and Duties:

Developing and submission of functional strategy in R&D, RA

Development and implementation of R&D and RA business processes and structure

Research, development and marketing authorization of new products on all markets

Member of Company Directors Board

Back to speakers
Irina Gorlova
CEO
SMD

 

Director of AFS Medizintechnik, the only distributor in Ukraine of Philips Health System.

In 1992, he graduated from Vinnytsia national technical university with honors Master degree in design engineering of radio-technical equipment.

He has great work experience at the Ukrainian market of medical equipment. From 2005 until 2015, he worked as Director of Ukrmedtechnika, the general representative of Toshiba Medical Systems in Ukraine. From 2015 until 2016, he hold leadership position in UMT, the distributor of world-famous medical equipment manufacturers Accuray, Hologic, Mediso.

Starting from August 2014, he has been actively engaged in the Association of market operators of medical devices (AMOMD) where he headed the functional committee on medical equipment. During this time, he actively supported all the non-regulatory initiatives of the Association. For the moment, he supports Association’s action to eliminate state price regulation on medical equipment purchased at the state budget expense. From 2017, he is Director of AFS Medizintechnik engaged in sale, supply, warranty and post warranty service of Philips medical equipment.

He is also engaged in public activities, pays great attention to initiatives to implement the latest technologies into the sphere of medicine.    

 

 

Komarov Yuriy Volodymyrovych

Education:

Taras Shevchenko National University of Kyiv in the field of nonlinear optics, 1994.

International Institute of Business, specializing in marketing, 1999

National Pharmaceutical University, specialty pharmacy, 2009.

Has a general experience in the pharmaceutical industry for 24 years working in a team of specialists of the leader of the pharmaceutical industry of Ukraine. Marketing and sales work for 22 years.

In 1994 year began his career in pharmaceuticals and from the post of a master of the production site of JSC "Farmak". In 1995 went to the sales department of the company. In 1999 he became the head of the department of marketing research, in 2006 - the head of the department of strategic marketing.

He has a successful expertise in the field of industry analytics, and the development of product portfolios.

Today he holds the position of head of the department of analytics of markets and brands portfolio of JSC "Farmak".

 

 

 

 

 

 

Sergey Goryslavets has been working at Glenmark Ukraine on Sales & Marketing Director position for 2,5 years, being responsible for strategic product portfolio development, SF development, short-term and long-term planning, managing team of professionals in marketing and sales areas. Totally, Sergey has over 20 years’ experience in pharmaceutical industry, starting from medical representative position up to his current role. His professional career have been lasting in number of original and generic pharmaceutical companies, dealing with various products. In 1997 Sergey graduated as a pharmacist from Zaporozhye State Medical University, holds master’s degree in economics from Kiev National Economic University (2003).

 

 

Pavlo graduated from O.O. Bogomolets National Medical University with a degree in  General Medicine as a General Practitioner − Family Doctor. Pavlo also got a degree in Pharmacy as a Pharmacist.

Pavlo Kharchyk started his career in the pharmaceutical busines while studying at the National Medical University as a representative, and later as a sales manager of  Bolear Med Co. After this company and graduation, he worked as a medical representative of the Beaufour Ipsen Pharma company in Ukraine. In parallel, he worked as an intern at KCCH No. 2. Then he acted as the director of the company “Kalina Pharma” and the marketing manager, and later the director of the “Kalina company for business development.” Today his main workplace is the “Kalina Medical Production Company”, where he works as a director.

During academic studies he received the awards  from the Kyiv mayor, an academic scholarship of the President of Ukraine. Representation office of “Beaufour Ipsen Pharma” awarded him by a certificate of the best medical representative of 2008 in the EurAsia 5 region.

He was rewarded “For the Service in Professional Activity” for his significant contribution to the development of Ukrainian economy.

 He was awarded by the honorary title “BEST MANAGER OF THE YEAR” for a significant contribution to the development of the Ukrainian economy and strong leadership in 2013.

 He holds the position of President of Association “Operators of the medical devices market” since 2012 for which he has been re-elected annually.

Implemented projects with P. Kharchyk participation:

 Draft Law No. 3180 “On the amendments to the item 193.1 “в” of article 193 of the Tax Code of Ukraine” dated by Sep. 25, 2015;

Cabinet of Ministers Resolution No. 181 “On the amendments of certain CMR decrees” dated by May 27, 2014;

Cabinet of Ministers Resolution No. 215 “On the amendments of certain CMR decrees” dated by July 01, 2014;

Cabinet of Ministers Resolution No. 216 “On approval of medical devices, which operations for delivery in the customs territory of Ukraine and importation into the customs territory of Ukraine are to be taxable for VAT at the rate of 7 percents” dated by July 01, 2014;

Cabinet of Ministers Resolution No. 240  “On the amendments of certain CMR decrees” dated by March 23, 2016;

Cabinet of Ministers Resolution No. 501   “On Amendments to the CMR reglament (in respect of changes to item 2 of paragraph 40 for Chapter 3)” dated by Aug. 08, 2016;

Cabinet of Ministers Resolution No. 43 ‘On Amendments to the CMR order of Oct. 17, 2008, No. 955 and to the CMR order of Jul. 02, 2014, No. 240” dated by January 25, 2017 – regarding the cancellation of change declaring of the wholesale-sale price for medical devices;

MHU order No. 660 “On the recognition of the MHU order of Dec. 29, 2011, No. 1000, as invalid one” dated by Oct. 09, 2015;

MHU order No.361 “On amending the MHU order of July 16, 2012 No. 533” dated by April 13, 2016.

 

Starting from July 2017 Vladimir Shtepa is working for BaDM LLC in the position of Deputy Commercial Officer on marketing ensuring the development and rendering of services on promotion of pharmaceutical products from the manufacturer to the ultimate consumer.

Vladimir has more than 18 years of experience in marketing and management of sales in the pharmaceutical field. In 1999 he started his professional career as a sales manager in Kiev-based Company “Vipex-Pharm” and shortly he was promoted to the position of administrative director of the regional branch.

From 2002 till 2008 he was engaged in the development of retail sales to the pharmacies and healthcare facilities as the representative of BaDM LLC. In 2009 Vladimir was appointed to the position of the Head of sales division responsible for logistics, distribution, and promotion of pharmaceutical products in the South-Eastern region.

Vladimir obtained his doctoral degree in medicine at Zaporizhia State Medical University and also the graduate diploma in marketing and management at Zaporizhzhya National University.

Currently, he lives in Dnipro. He’s married and has two children; in his spare time he enjoys improvisation on the piano, goes in for sports and takes online courses on marketing and market environment. 

Yuliya Shchehlova,  graduated from Kharkov Pharmaceutical Academy with Pharmacists Diploma. She also has a 'Marketing degree' from National Pharmaceutical University of Management & Economy, Kharkov 

Before her role as a Senior Product Manager in the Representative Office Takeda, Ukraine

Yuliya used to be  a Product Manager in the Representative office of  Mepha in Ukraine.

Would you like to join our Speaker Faculty?

To find out more about speaking opportunities please contact:

Diana Koumi
Tel: +44 203 9504820
Email: d.koumi@adamsmithconferences.com